growacet's Recent Posts
Title Rating ▼ Company Posted on
Re: Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017 4 Resverlogix Corp. Jul 25, 2017 09:47PM
Re: AGM....DND 4 Resverlogix Corp. Sep 12, 2018 11:35PM
A replay of 2 years ago would sure be nice.... 4 Resverlogix Corp. Mar 08, 2017 11:42AM
Re: Thoughts 4 Resverlogix Corp. Oct 01, 2019 07:14AM
Is a SSRA really needed? 4 Resverlogix Corp. Jun 08, 2018 03:03PM
TSX Buy-In CDS - $1.60 printed 4 Resverlogix Corp. Jun 08, 2018 03:08PM
Re: Esperion news, has this been discussed? 4 Resverlogix Corp. Jan 15, 2019 11:21AM
Short interest for the past year... 4 Resverlogix Corp. Jul 10, 2019 06:44AM
Re: Anacetrapib Officially Bites the Dust 4 Resverlogix Corp. Oct 28, 2017 08:59PM
More chart gazing....cup and handle 4 Resverlogix Corp. Aug 14, 2015 02:37AM
Sample Size Recalculation Analysis ('SSRA')???? 4 Resverlogix Corp. Jan 12, 2018 01:15AM
Re: Will Apabetalone end up in China first? 4 Resverlogix Corp. Aug 05, 2018 11:16AM
Re: The Top 5 TSX Biotechs for 2018 so far - Guess which one they missed..... 4 Resverlogix Corp. Dec 25, 2018 07:59PM
Re: Small Financing...... 4 Resverlogix Corp. Jun 09, 2017 09:16PM
Short interest drops significantly..... 4 Resverlogix Corp. Aug 06, 2015 11:27PM
The market is filled with Nostradamus types... 4 Resverlogix Corp. Oct 28, 2017 09:35PM
Re: Looking into Delivery Failures and forced buy ins.... 4 Resverlogix Corp. Jun 15, 2018 06:01AM
Re: Sep 30 AGM Notes - Detailed 4 Resverlogix Corp. Oct 05, 2015 05:27PM
Man....talk about tightly held 4 Resverlogix Corp. Jan 05, 2016 10:54AM
Re: New blog entry: Disrupting Treatment of Cardiovascular Disease with Epigenetics 4 Resverlogix Corp. Aug 26, 2015 05:50PM